Please login to the form below

Not currently logged in
Email:
Password:

presbyopia

This page shows the latest presbyopia news and features for those working in and with pharma, biotech and healthcare.

Novartis buys two firms in pre-Christmas shopping spree

Novartis buys two firms in pre-Christmas shopping spree

The takeover of Encore gives Novartis rights to EV06 (lipoic acid choline ester), a disease-modifying treatment for age-related loss of near distance vision (presbyopia) that can be delivered in ... Presbyopia affects 80% of people aged over 45 and makes

Latest news

  • FDA approves wireless contact lens sensor FDA approves wireless contact lens sensor

    In eye care Novartis has licensed the rights to Google's smart lens technology and is developing it for use in diabetes and presbyopia, with clinical trials due to begin later

  • You're in good hands You're in good hands

    Are we throwing expensive presbyopia-correcting intraocular lenses for cataract patients into this basket of goods?

  • Novartis buys rights to Google's 'smart lens' technology Novartis buys rights to Google's 'smart lens' technology

    Pharma company's eye unit Alcon will focus on uses in diabetes and presbyopia.  . ... The other is to help people with presbyopia – age-related long-sightedness that makes it more difficult to focus on objects that are near.  .

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

PRO
Integrating patient reported outcomes into clinical trials
How capturing the patient voice is unlocking medicines’ commercial potential...
Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...

Infographics